Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$671,398
-$244,515 QoQ
Shares Held
27,882
-14.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,562
of 2,834 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCF Advisors LLC holds $26,128,918 across 16 Drug Manufacturers - General names. PFE ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,362 | $6,441,187 | |
| 2 | AMGN |
Amgen Inc
|
12,335 | $4,466,750 | |
| 3 | LLY |
ELI LILLY & Co
|
3,535 | $4,239,985 | |
| 4 | ABBV |
AbbVie Inc.
|
12,627 | $3,177,458 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,882 | $3,068,837 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
21,492 | $2,715,299 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,023 | $980,865 | |
| 8 | PFE |
Pfizer Inc
This page
|
27,882 | $671,398 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $671,398 | 27,882 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $915,913 | 32,618 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $676,682 | 27,176 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $371,498 | 14,580 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $348,110 | 14,361 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $518,937 | 20,479 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $474,807 | 17,897 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $532,727 | 18,408 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $448,911 | 16,044 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $591,102 | 21,301 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $664,559 | 23,083 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $915,160 | 27,590 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $976,238 | 26,615 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,083,852 | 26,565 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,296,269 | 25,298 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,118,855 | 25,568 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $948,091 | 18,083 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $919,538 | 17,762 | Shares | Sole | 2022-05-05 | |
| 2021-09-30 | $798,824 | 18,573 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $684,869 | 17,489 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $496,024 | 13,691 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $562,972 | 15,294 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $728,420 | 19,848 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $346,456 | 10,595 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $345,722 | 10,592 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||